Literature DB >> 29533741

Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity.

Li-Hao Huang1, Elaina M Melton1, Haibo Li1, Paul Sohn1, DaeYoung Jung2, Ching-Yi Tsai3, Tian Ma4, Hiroyuki Sano1, HyeKyung Ha2, Randall H Friedline2, Jason K Kim2, Edward Usherwood3, Catherine C Y Chang1, Ta-Yuan Chang1.   

Abstract

Macrophages are phagocytes that play important roles in health and diseases. Acyl-CoA:cholesterol acyltransferase 1 (ACAT1) converts cellular cholesterol to cholesteryl esters and is expressed in many cell types. Unlike global Acat1 knockout (KO), myeloid-specific Acat1 KO ( Acat1-) does not cause overt abnormalities in mice. Here, we performed analyses in age- and sex-matched Acat1-M/-M and wild-type mice on chow or Western diet and discovered that Acat1-M/-M mice exhibit resistance to Western diet-induced obesity. On both chow and Western diets, Acat1-M/-M mice display decreased adipocyte size and increased insulin sensitivity. When fed with Western diet, Acat1-M/-M mice contain fewer infiltrating macrophages in white adipose tissue (WAT), with significantly diminished inflammatory phenotype. Without Acat1, the Ly6Chi monocytes express reduced levels of integrin-β1, which plays a key role in the interaction between monocytes and the inflamed endothelium. Adoptive transfer experiment showed that the appearance of leukocytes from Acat1-M/-M mice to the inflamed WAT of wild-type mice is significantly diminished. Under Western diet, Acat1-M/-M causes suppression of multiple proinflammatory genes in WAT. Cell culture experiments show that in RAW 264.7 macrophages, inhibiting ACAT1 with a small-molecule ACAT1-specific inhibitor reduces inflammatory responses to lipopolysaccharide. We conclude that under Western diet, blocking ACAT1 in macrophages attenuates inflammation in WAT. Other results show that Acat1-M/-M does not compromise antiviral immune response. Our work reveals that blocking ACAT1 suppresses diet-induced obesity in part by slowing down monocyte infiltration to WAT as well as by reducing the inflammatory responses of adipose tissue macrophages.

Entities:  

Keywords:  ACAT; cholesterol; diabetes; macrophage; obesity

Mesh:

Substances:

Year:  2018        PMID: 29533741      PMCID: PMC6171008          DOI: 10.1152/ajpendo.00174.2017

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  60 in total

1.  Effects of 5-fluorouracil on the hematopoietic system of the mouse.

Authors:  A LINDNER; D SANTILLI; J HODGETT; C NERLINGER
Journal:  Cancer Res       Date:  1960-05       Impact factor: 12.701

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

4.  A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.

Authors:  Mami Ikenoya; Yasunobu Yoshinaka; Hideyuki Kobayashi; Katsumi Kawamine; Kimiyuki Shibuya; Fumiyasu Sato; Kimio Sawanobori; Takuya Watanabe; Akira Miyazaki
Journal:  Atherosclerosis       Date:  2006-07-03       Impact factor: 5.162

Review 5.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

6.  High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.

Authors:  Christina A Bursill; Maria L Castro; Douglas T Beattie; Shirley Nakhla; Emiel van der Vorst; Alison K Heather; Philip J Barter; Kerry-Anne Rye
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-11       Impact factor: 8.311

7.  Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells.

Authors:  C C Chang; H Y Huh; K M Cadigan; T Y Chang
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

8.  Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

Authors:  S Fazio; A S Major; L L Swift; L A Gleaves; M Accad; M F Linton; R V Farese
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

9.  Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts.

Authors:  Yoshio Yamauchi; Catherine C Y Chang; Michi Hayashi; Sumiko Abe-Dohmae; Patrick C Reid; Ta-Yuan Chang; Shinji Yokoyama
Journal:  J Lipid Res       Date:  2004-08-01       Impact factor: 5.922

10.  Increased macrophage migration into adipose tissue in obese mice.

Authors:  Da Young Oh; Hidetaka Morinaga; Saswata Talukdar; Eun Ju Bae; Jerrold M Olefsky
Journal:  Diabetes       Date:  2011-12-21       Impact factor: 9.461

View more
  7 in total

1.  Nanodisc scaffold peptide (NSPr) replaces detergent by reconstituting acyl-CoA:cholesterol acyltransferase 1 into peptidiscs.

Authors:  Bryan Neumann; Kevin Chao; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Arch Biochem Biophys       Date:  2020-07-28       Impact factor: 4.013

2.  Myeloid Acat1/Soat1 KO attenuates pro-inflammatory responses in macrophages and protects against atherosclerosis in a model of advanced lesions.

Authors:  Elaina M Melton; Haibo Li; Jalen Benson; Paul Sohn; Li-Hao Huang; Bao-Liang Song; Bo-Liang Li; Catherine C Y Chang; Ta-Yuan Chang
Journal:  J Biol Chem       Date:  2019-09-08       Impact factor: 5.157

3.  α-Mangostin remodels visceral adipose tissue inflammation to ameliorate age-related metabolic disorders in mice.

Authors:  Dan Li; Qianyu Liu; Xiuqiang Lu; Zhengqiu Li; Chunming Wang; Chung-Hang Leung; Yitao Wang; Cheng Peng; Ligen Lin
Journal:  Aging (Albany NY)       Date:  2019-12-06       Impact factor: 5.682

4.  Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy.

Authors:  Harrison M Penrose; Rida Iftikhar; Morgan E Collins; Eman Toraih; Emmanuelle Ruiz; Nathan Ungerleider; Hani Nakhoul; Erik F Flemington; Emad Kandil; Shamita B Shah; Suzana D Savkovic
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

Review 5.  Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy.

Authors:  Chen Chen; Zehua Wang; Yanru Qin
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

6.  Immune Cells and Transcriptional Signatures Revealed Novel Regulators and Predict Clinical Response to Biologic Therapy in Ulcerative Colitis.

Authors:  Suzana D Savkovic
Journal:  J Cell Immunol       Date:  2021

7.  Effects of Simultaneous Exposure to a Western Diet and Wheel-Running Training on Brain Energy Metabolism in Female Rats.

Authors:  Marta Maria Nowacka-Chmielewska; Daniela Liśkiewicz; Konstancja Grabowska; Arkadiusz Liśkiewicz; Łukasz Marczak; Anna Wojakowska; Natalia Pondel; Mateusz Grabowski; Jarosław Jerzy Barski; Andrzej Małecki
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.